Legislative Activity

The Americas Regional Monitoring of Arms Sales (ARMAS) Act of 2025 seeks to combat illegal firearms trafficking to Mexico, Central America, and the Caribbean. It transfers regulatory control of certain munitions exports from the Department of Commerce back to the Department of State. The bill also mandates comprehensive reporting, strategy development, and increased tracking of U.S. firearm exports to designated "covered countries."

The Protect America's Workforce Act nullifies a specific Executive Order issued in March 2025 concerning exclusions from federal labor-management relations programs. This legislation ensures that any existing collective bargaining agreements between federal agencies and employee unions remain fully in effect until their stated expiration dates. The Act also prohibits the use of federal funds to implement the overturned Executive Order.

The ePermit Act mandates the creation of a unified, digital system for managing all federal environmental reviews and project permits. This system will standardize data, automate processes, and provide real-time public access to review status and documents. The goal is to increase transparency, efficiency, and data interoperability across federal agencies involved in project authorizations.

The Adams Memorial-Great American Heroes Act extends the authority of the Adams Memorial Commission until 2032 and approves a specific location for the memorial, allowing it to proceed despite certain location standards. The bill also grants the Commission flexibility to relocate the memorial to the "Reserve" if the primary site proves unsuitable. Finally, it makes technical amendments to existing law to align dates and clarify the memorial's authorization.

The READ AI Models Act establishes a pilot program, managed by NIST, to create standardized documentation for artificial intelligence models and their training data. This initiative will develop a flexible template and technical guidelines, incorporating stakeholder input, to ensure transparency about AI model development. Following a review, NIST will report on the program's effectiveness and potentially establish permanent documentation standards.

The HELP Copays Act requires that financial assistance provided by non-profit organizations and drug manufacturers must count toward a patient's deductible, copayments, and out-of-pocket maximums for prescription drugs. This change ensures that patient assistance dollars directly reduce the amount a patient must pay before their coverage fully kicks in. The legislation specifically applies to specialty drugs and those subject to utilization management. These provisions will take effect for plan years beginning on or after January 1, 2026.

This resolution strongly condemns the Iranian government for its ongoing, state-sponsored persecution of the Baha'i religious minority, which violates international human rights laws. It documents systematic abuses, including economic restrictions, denial of education, and arbitrary arrests, noting that these actions may constitute a crime against humanity. The resolution calls on Iran to immediately release all imprisoned Bahais and urges the U.S. President and Secretary of State to condemn these violations and impose sanctions on responsible officials.

The Mikaela Naylon Give Kids a Chance Act focuses primarily on improving pediatric drug development and ensuring patient access to necessary treatments. This legislation mandates new research requirements for molecularly targeted pediatric cancer drugs, strengthens FDA enforcement of pediatric study completion, and extends incentives for developing drugs for rare pediatric diseases. Additionally, the bill updates organ transplant network functions and establishes an Abraham Accords Office within the FDA to enhance international regulatory cooperation.

The Alzheimer’s Screening and Prevention Act of 2025 (ASAP Act) amends Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting in 2028. This coverage applies to FDA-cleared tests, including genomic sequencing and other equivalent diagnostic methods, designed to detect pre-symptomatic or early-stage conditions. The bill ensures these screenings are added to the list of covered medical services under Medicare.

The AIM Act primarily focuses on eliminating numerous existing statutory restrictions and prohibitions that currently limit the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) in its operations. This includes removing limitations on the use and analysis of firearms trace data and allowing for the consolidation of dealer records. Furthermore, the bill removes requirements for the destruction of background check records and eases restrictions on the ATF's ability to inspect dealer inventories and deny or revoke Federal Firearms Licenses.

The Bivens Act of 2025 amends existing law to redefine the scope of civil actions that can be brought against individuals acting under federal authority. This legislation specifically revises Section 1979 of the Revised Statutes concerning such lawsuits. The core change narrows the focus of these civil actions to exclusively target persons acting under the authority of the United States.

The Biomanufacturing Excellence Act of 2025 aims to bolster U.S. leadership in biotechnology by establishing a National Biopharmaceutical Center of Excellence. This Center will accelerate manufacturing innovation, strengthen domestic supply chains, and ensure adherence to quality standards. It will also facilitate crucial workforce training to support the growing biomanufacturing sector.

The Health ACCESS Act amends federal law to create an exception to prohibitions against offering remuneration to influence healthcare decisions. This change specifically allows providers to pay information service platforms for participation, provided the platform adheres to strict guidelines ensuring unbiased consumer choice. These guidelines prohibit steering patients, targeted marketing, and sharing consumer contact information outside of a confirmed selection. Ultimately, this bill aims to facilitate easier consumer access to healthcare providers through regulated self-scheduling platforms.

The Restoring Food Security for American Families and Farmers Act of 2025 aims to strengthen domestic food security by repealing specific sections of a prior reconciliation act. This action effectively revives the original laws that were previously amended by the repealed provisions. The bill seeks to revert existing agricultural and food-related statutes to their pre-amendment status.

The Stop Excessive Force in Immigration Act of 2025 establishes strict new standards for the use of non-deadly force by federal immigration personnel, requiring proportionality and de-escalation efforts. The bill mandates identification requirements, restricts the use of certain crowd-control equipment, and imposes new body camera and detailed reporting mandates. Furthermore, it creates affirmative duties for officers to intervene against excessive force and requires annual training on these new policies.

This resolution expresses strong support for Gavi, the Vaccine Alliance, recognizing its critical role in saving children's lives through global immunization efforts in low-income countries. It highlights Gavi's proven success in delivering vaccines, strengthening health systems, and providing a significant return on investment. The bill encourages the U.S. to maintain and increase its financial commitment to Gavi to ensure global health security and future vaccine access.

The REPO for Ukrainians Implementation Act of 2025 formally recognizes international calls to repurpose frozen Russian sovereign assets to aid Ukraine. This bill grants the President authority to transfer non-confiscated Russian assets into the Ukraine Support Fund, where they must be invested in U.S. government debt. Furthermore, the Secretary of State is mandated to obligate at least $250 million from the fund to Ukraine every quarter. The Act also requires the President to report on the location of these Russian assets globally and directs diplomatic efforts to encourage allies to contribute quarterly.

The Penicillin Allergy Verification and Evaluation (PAVE) Act addresses the widespread issue of inaccurate penicillin allergy labels, which often lead to poorer patient outcomes. This bill mandates that Medicare cover and require physicians to perform a formal penicillin allergy verification and evaluation for seniors during their initial and annual wellness visits. The goal is to correctly identify patients who can safely take penicillin, improving care and promoting responsible antibiotic stewardship.

This resolution strongly condemns the brutal October 7th attacks by Hamas, demanding the immediate and unconditional surrender of the terrorist group and the release of all hostages, including Americans. It reaffirms Israel's right to self-defense while urging international action against Hamas and condemning the global surge in antisemitism. The measure serves as a formal statement of U.S. policy and support following the attacks.

This bill ensures that states are reimbursed by the Federal Government for any state funds they use to maintain essential operations of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) during a lapse in federal appropriations. It provides a mechanism for the Federal Government to pay back states that cover WIC costs during a government shutdown. This protects state budgets while keeping vital nutrition assistance running.